Jean–Jacques Raabe

886 total citations
7 papers, 114 citations indexed

About

Jean–Jacques Raabe is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, Jean–Jacques Raabe has authored 7 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Hepatology and 2 papers in Rheumatology. Recurrent topics in Jean–Jacques Raabe's work include Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Systemic Lupus Erythematosus Research (2 papers). Jean–Jacques Raabe is often cited by papers focused on Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Systemic Lupus Erythematosus Research (2 papers). Jean–Jacques Raabe collaborates with scholars based in France, Estonia and Philippines. Jean–Jacques Raabe's co-authors include Dominique Roulot, Lawrence Serfaty, F. Oberti, Xavier Causse, Claude Masliah, T Davion, Gilles Pelletier, Albert Tran, H Labadie and Odile Goria and has published in prestigious journals such as Hepatology, Journal of Hepatology and Clinical Gastroenterology and Hepatology.

In The Last Decade

Jean–Jacques Raabe

7 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean–Jacques Raabe France 5 82 80 14 14 11 7 114
Mansour Altuwaijri Saudi Arabia 5 58 0.7× 41 0.5× 22 1.6× 11 0.8× 6 0.5× 16 131
Kannika Phornphutkul Thailand 6 51 0.6× 54 0.7× 10 0.7× 30 2.1× 16 1.5× 11 125
Enrique Carrera Argentina 8 63 0.8× 61 0.8× 29 2.1× 20 1.4× 28 2.5× 15 154
E Özyılkan Türkiye 7 44 0.5× 54 0.7× 29 2.1× 21 1.5× 11 1.0× 20 125
Raffaella Viganò Italy 7 44 0.5× 71 0.9× 18 1.3× 8 0.6× 12 1.1× 13 105
Mohamed Zein Egypt 5 48 0.6× 15 0.2× 10 0.7× 16 1.1× 7 0.6× 8 107
Hanaa Badran Egypt 9 174 2.1× 176 2.2× 7 0.5× 10 0.7× 8 0.7× 21 238
Yajing Zang United Kingdom 2 95 1.2× 37 0.5× 14 1.0× 35 2.5× 8 0.7× 2 134
Zeeshan Ahmad Wani India 5 102 1.2× 108 1.4× 18 1.3× 4 0.3× 3 0.3× 14 153
Korenobu Hayama Japan 7 98 1.2× 61 0.8× 32 2.3× 25 1.8× 16 1.5× 14 145

Countries citing papers authored by Jean–Jacques Raabe

Since Specialization
Citations

This map shows the geographic impact of Jean–Jacques Raabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean–Jacques Raabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean–Jacques Raabe more than expected).

Fields of papers citing papers by Jean–Jacques Raabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean–Jacques Raabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean–Jacques Raabe. The network helps show where Jean–Jacques Raabe may publish in the future.

Co-authorship network of co-authors of Jean–Jacques Raabe

This figure shows the co-authorship network connecting the top 25 collaborators of Jean–Jacques Raabe. A scholar is included among the top collaborators of Jean–Jacques Raabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean–Jacques Raabe. Jean–Jacques Raabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Zarski, Jean‐Pierre, Nathalie Stürm, Hervé Desmorat, et al.. (2010). Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study. Liver International. 30(7). 1049–1058. 11 indexed citations
2.
Zarski, Jean‐Pierre, Nathalie Stürm, Hervé Desmorat, et al.. (2008). 841 EFFICACY AND SAFETY OF 2 YEARS MAINTENANCE THERAPY WITH PEGINTERFERON ALPHA-2A IN CHRONIC HEPATITIS C: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (FIBROSYS). Journal of Hepatology. 48. S315–S316. 1 indexed citations
3.
Fartoux, Lætitia, Françoise Degos, Christian Trépo, et al.. (2007). Effect of Prolonged Interferon Therapy on the Outcome of Hepatitis C Virus–Related Cirrhosis: A Randomized Trial. Clinical Gastroenterology and Hepatology. 5(4). 502–507. 33 indexed citations
4.
Pelletier, Gilles, Dominique Roulot, T Davion, et al.. (2003). A Randomized Controlled Trial of Ursodeoxycholic Acid in Patients With Alcohol–Induced Cirrhosis and Jaundice. Hepatology. 37(4). 887–892. 30 indexed citations
5.
Queneau, P, Jean-Pierre Bronowicki, Gérard Thiéfin, et al.. (2001). Treatment of mild chronic hepatitis C with interferon α-2b: results of a multi-centre randomized study in 80 patients. European Journal of Gastroenterology & Hepatology. 13(2). 143–147. 3 indexed citations
6.
Maynard-Muet, M., S. Chousterman, R Barnoud, et al.. (1998). Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon. Hepatology. 27(3). 862–867. 25 indexed citations
7.
Raabe, Jean–Jacques, et al.. (1982). A Rare Etiology of Ischemic Colitis - Amyloid Colitis. Endoscopy. 14(3). 107–109. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026